Lv41
741 积分 2021-06-02 加入
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
42分钟前
待确认
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
1小时前
已完结
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell
1个月前
已完结
Genetic Modification of T Cells with Chimeric Antigen Receptors: A Laboratory Manual
1个月前
已完结
Prospective phase I/II study of CD19-directed CAR-t therapy in relapsed/refractory central nervous system lymphoma: Clinical outcomes and safety profile
1个月前
已完结
Co-opting signalling molecules enables logic-gated control of CAR T cells
1个月前
已完结
Optimization of canine CD20 chimeric antigen receptor T cell manufacturing and in vitro cytotoxic activity against B‐cell lymphoma
1个月前
已完结
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
1个月前
已完结
HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
1个月前
已完结
A Truncated Human NKG2D Splice Isoform Negatively Regulates NKG2D-Mediated Function
1个月前
已完结
皖公网安备34019202002308
